Pragati Coder headshot

Pragati S. Coder, PhD, DABT, ATS

Global Lead, Developmental and Reproductive Toxicology (C&C)

Pragati Coder is one of the Global Scientific Leads for Developmental and Reproductive Toxicology (DART; C&C) and also serves as Senior Director, DART, Juvenile and Neurotoxicology at Charles River’s Ashland, OH site. Dr. Coder is a subject matter expert for developmental, reproductive, endocrine, neurotoxicity, and juvenile toxicity studies that support product development programs for pharmaceutical, (agro)chemical, and veterinary medical products.

She received her doctorate in molecular biology from Indian Institute of Technology-Bombay, India and was a postdoctoral fellow in reproductive toxicology at the College of Pharmacy, The University of Texas at Austin. Dr. Coder is board-certified as a Diplomate of the American Board of Toxicology and a Fellow of the Academy of Toxicological Sciences. She is an active member of the international DART scientific community and several professional organizations, including the Society of Toxicology, Society for Birth Defects Research and Prevention (BDRP, formerly Teratology Society), Health and Environmental Science Institute (HESI-DART), European Teratology Society and the Middle Atlantic Reproduction and Teratology Association (MARTA). She has served in various official capacities in these organizations. Most recently, she served as President for the Society for Birth Defects Research and Prevention (2025-2026).

Connect with Dr. Coder on LinkedIn

Vortex-like particle flow visualization, suggesting fluid dynamics or energy field simulation

WEBINAR SERIES
Advance Your DART Programs with New Approach Methodologies (NAMs)
Join us for a two-part webinar series that will explore how chemical companies can strategically integrate NAMs and in vitro methods into testing and development workflows. Learn More

abstract

Re-examining DART Dose Level Selection for ECHA Submissions
View this webinar where we share our experiences conducting over 130 EOGRT studies and our ongoing discussions with ECHA
Watch the Webinar